LRRK2 and Parkinson disease: Consistent with this finding, the LRRK2 R1441G pathogenic mutant and importantly the WD40 domain G2385R PD risk variant also reduce pathway activation relative to wild-type LRRK2 in SH-SY5Y cells (Figure 5A).